Previous close | 53.19 |
Open | 53.59 |
Bid | 53.21 x 800 |
Ask | 54.28 x 800 |
Day's range | 53.09 - 53.98 |
52-week range | 39.33 - 54.51 |
Volume | |
Avg. volume | 2,134,416 |
Market cap | 21.757B |
Beta (5Y monthly) | 1.36 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.80 (3.38%) |
Ex-dividend date | 01 July 2024 |
1y target est | N/A |
Ventas' (VTR) Q2 earnings are likely to have benefitted from favorable SHOP operating trends, healthy demand for life-science real estate assets and accretive investments.
Alexandria's (ARE) Q2 AFFO outshines estimates. Results reflect decent leasing activity and higher rental rates.
Ventas (VTR) is poised to benefit by leveraging the rise in the aging population, growing outpatient visit trends and a healthy balance sheet. However, higher competition and interest rates are headwinds.